By proceeding, you agree to our
Biotech Showcase will give you the opportunity to connect with your peers in-person in San Francisco this January. Not ready to travel? Take advantage of our Digital Pass to still be part of the busiest week in healthcare. This event gives you the opportunity to find thousands of investment opportunities.
Showcase your innovations in front of the entire Biotech community.
Deep dive into Digital Medicine and Medtech Showcase, Bioelectronic Medicine, Business Trends in Asia Pacific, Finance Trends in Asia Pacific & more!
Grab the chance to meet the right investors and get in front of the right decision-makers during the most important fund-raising week.
Connect with your peers in-person. Find & leverage thousands of investment opportunities.
25-28 September 2023
Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
26-27 September 2023
The coronavirus pandemic ignited interest in learning more about immune responses to infections, their downstream effects, and how they can be modulated. It also gave rise to increased awareness of the role of immunity in diseases like cancer, neurod
Cambridge Healthtech Institute’s two-part conference on Artificial Intelligence (AI)/Machine Learning (ML)-Enabled Drug Discovery will highlight the increasing use of computational tools, AI modeling, algorithms, and data science for identifying nove
While finding novel druggable targets and drug modalities for therapeutic intervention remains a top priority for the pharma/biotech industry, identifying and validating "good" targets and leads remains challenging. Cambridge Healthtech Institute’s c
Cambridge Healthtech Institute's GPCR-Based Drug Discovery conference is now in its 18th year. G protein-coupled receptors (GPCRs), because of their central role in so many cellular processes, are still among the largest class of molecules modulated
Small molecule-based therapeutic options against traditionally hard-to-drug intracellular oncology targets (like KRAS) are being discovered at a more rapid pace and a few have even reached the market in the past few years. Not only do small molecules
As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an altern
A new generation of molecules are being developed to disrupt protein-protein interactions and to hijack the cell’s natural machinery for targeted protein degradation. Proteolysis-targeting chimeras (PROTACs), molecular glues, and other modalities are
Cambridge Healthtech Institute's 2nd Annual Neurodegeneration Targets conference focuses on therapeutic candidates in clinical or earlier stage development that modulate molecules or cellular processes involved in neurodegenerative diseases, especial
The first pass category is available exclusively to Pharma, Biopharmaceutical and Medical Device companies. Eligibility is subject to approval by the Arena International team.The second pass category is available to vendors, service provi
EBD Group, part of Informa Connect, is the leading partnering firm for the global biotechnology industry.
At Charles River, we are passionate about our role in improving the quality of people’s lives.
Parexel is focused on the development of innovative new therapies to improve the world’s health.
Syneos Health® is the only fully integrated end-to-end clinical and commercial solution organization.
Founded in 1978, Biogen is a pioneer in biotechnology and today the Company has the leading portfolio of medicines to treat multiple sclerosis, has introduced the first and only approved treatment for spinal muscular atrophy, and is at the forefront
ICON plc is a global provider of outsourced drug development and commercialisation solutions and services to pharmaceutical, biotechnology, medical device, and government and public health organisations.
Ipsen is a global mid-size biopharmaceutical company with a focus on transformative medicines in Oncology, Neuroscience and Rare Disease. Under the overarching theme of Focus. Together.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.
Profound Change Requires Boldness. Johnson & Johnson is the largest and most broadly based healthcare company in the world. We’re producing life-changing breakthroughs every day, and have been for the last 130 years.
For nearly 40 years, Silicon Valley Bank (SVB) has helped innovative companies and their investors move bold ideas forward, fast.
Straight talking. Thinking around corners. Understanding and solving the problem before it becomes a problem. Performing as a team, no matter where we’re sitting. Delivering clear and practical advice that gets your job done.
Bringing together the most dynamic minds in science, tech, engineering and innovation, we contract with pharma companies of all sizes, making vital connections between innovator and tool, science and creativity, human and cure.
For over 25 years, FUJIFILM Diosynth Biotechnology’s mission has been advancing tomorrow’s medicine.
XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies.
AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO), with a relentless commitment to deliver the highest standard of service to our clients and partners.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.
Novotech is a leading Asia-Pacific biotech specialist CRO and consists of two operating brands, "Novotech" and "PPC". Novotech is a full-service clinical CRO with labs, phase I facilities, and drug development consulting services.
BioCina is a biologics contract development and manufacturing organization (CDMO) specializing in process development and cGMP manufacture of microbial-based therapeutics and plasmid DNA, from preclinical to commercial production.
CG Life is an integrated marketing communications agency focused on life science and healthcare. We work with biotech, research tools/instrumentation, medical device, diagnostics, pharmaceutical, and chemical companies of all sizes around the globe.
Content Carnivores is dedicated to delivering the highest standards of ideas and writing so that greatness finds its widest audience to deliver on business objectives.
EMD Serono is the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, employing over 1,200 individuals around the country with U.S. headquarters located in Rockland, Massachusetts.
Astellas Pharma is a pharmaceutical company conducting business in more than 70 countries around the world.
From our offices in Beijing, Brussels, Dubai, Frankfurt, Johannesburg, London, Los Angeles, New York, Palo Alto, San Francisco, Seoul, Shanghai, and Washington, we practice as one firm, holding closely to core values that start with a deep commitment
Sumitomo Mitsui Financial Group, Inc. (SMFG) is the holding company of SMBC Group, which is one of the three largest banking groups in Japan. In the Americas, we are more than 3,000 employees strong with a presence in the U.S.
Foley Hoag is a dynamic law firm that represents public and private clients in a wide range of disputes and transactions worldwide.
Triangle Insights Group, LLC is a strategy consulting firm providing guidance on the most critical business issues to leaders in life sciences organizations.
SmartLabs is accelerating the pace of scientific discovery by radically transforming the way the world builds and uses lab space.
JamesDruryPartners is a senior level management consulting firm specializing in board advisory services and executive board placement. Our extensive board and governance practice is one of the most diverse in our industry.
Blue Matter is a specialized management consulting firm, founded in San Francisco with offices in the US and Europe. We work with life sciences clients to address business issues across the company and product value chain.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.